The use of U-500 in patients with extreme insulin resistance.

@article{Cochran2005TheUO,
  title={The use of U-500 in patients with extreme insulin resistance.},
  author={Elaine K. Cochran and Carla Musso and Phillip Gorden},
  journal={Diabetes care},
  year={2005},
  volume={28 5},
  pages={
          1240-4
        }
}
The Diabetes Control and Complication Trial (1) and the U.K. Prospective Diabetes Study (2,3), as well as other smaller trials (4), have established the benefit of treating type 1 and type 2 diabetes to levels of glycemia as close to normal as possible. These studies have formed the basis for the therapeutic targets set forth in the most recent American Diabetes Association (ADA) guidelines (5). There is a subset of patients classified by the ADA as having “other specific types of diabetes… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 46 CITATIONS

Pharmacologic treatment of type 2 diabetes: injectable medications.

  • The Annals of pharmacotherapy
  • 2015
VIEW 3 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

Stan - dards of medical care in diabetes ( Position Statement )

EA Kerr, RB Gerzoff, +8 authors CM Mangione
  • Diabetes Care
  • 2004